Aktieanalys

Cellavision Q2 2025: Stable with Decent Growth - Redeye

{newsItem.title}

Redeye Publicerad: 21 Jul 08:45

Redeye comments on Cellavision's first quarter 2025, which saw organic sales growth of 8%, with the highest growth in ASEA. We make limited changes to our forecast.

Länk till analysen i sin helhet: https://www.redeye.se/research/1119494/cellavision-q2-2025-stable-with-decent-growth?utm_source=finwire&utm_medium=RSS

Nyheter om CellaVision

Läses av andra just nu

Om aktien CellaVision

Senaste nytt